HF
VRCA icon

HRT Financial’s Verrica Pharmaceuticals VRCA Stock Holding History

HRT Financial’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79K Buy
+13,023
New +$81.2K ﹤0.01% 3673
2026
Q1 		– Sell
-17,356
Closed -$144K – 4809
2025
Q4 		$144K Buy
+17,356
New +$96.2K ﹤0.01% 2715
2025
Q2 		– Sell
-4,148
Closed -$18K – 3598
2025
Q1 		$18K Sell
4,148
-3,138
-43% -$20.3K ﹤0.01% 2314
2024
Q4 		$51K Buy
7,286
+2,438
+50% +$26.8K ﹤0.01% 2109
2024
Q3 		$70K Buy
+4,848
New +$218K ﹤0.01% 2076
2023
Q2 		– Sell
-2,646
Closed -$172K – 3356
2023
Q1 		$172K Buy
+2,646
New +$160K ﹤0.01% 1957
2022
Q4 		– Sell
-1,141
Closed -$33K – 3219
2022
Q3 		$33K Buy
1,141
+126
+12% +$4.32K ﹤0.01% 2464
2022
Q2 		$19K Buy
+1,015
New +$51K ﹤0.01% 2613

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HRT Financial's VRCA Position: Q2 2026 in Review

HRT Financial opened a new position in Verrica Pharmaceuticals (VRCA) in Q2 2026: 13,023 shares worth $79K. The stake represents ﹤0.01% of the portfolio and ranks #3673 among its holdings. This is a return to the name: HRT Financial previously reported a position in VRCA as recently as Q4 2025.

HRT Financial first reported a position in VRCA in Q2 2022 and has held it in 8 quarters since. The position peaked at $172K in Q1 2023. 43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • HRT Financial held 13,023 shares of Verrica Pharmaceuticals worth $79K as of Q2 2026.
  • Verrica Pharmaceuticals was a new HRT Financial position in Q2 2026.
  • Verrica Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3673 holding.
  • HRT Financial first reported a position in Verrica Pharmaceuticals in Q2 2022 and has held it in 8 quarters since.
  • HRT Financial's Verrica Pharmaceuticals position peaked at $172K in Q1 2023.
  • 43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.